Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to give blood specimen for lab investigations Haemoglobin level within 8.1 - 10.9 gm Blood smear shows microcytic hypochromic anemia Patients with signs such as Pallor of skin, mucous membrane, conjuctiva and nail beds and any two of following symptoms such as lack of concentration, malaise, anorexia, headache, palpitation
Exclusion criteria
Exclusion criteria: Patient with chronic disease Known case of any other hematological disorder Patient not willing to give blood sample for investigation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome of the clinical study will be assessed by baseline increase in Hb level MCV MCH MCHC PCV & Serum Ferritin levels before & after treatmentTimepoint: 48th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Physiochemical analysis of the drug will be standardisedTimepoint: 6 months | — |
Countries
India
Contacts
National Institute of Siddha